MEDICO35.00

Medico Remedies Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersMEDICAMEQHALEOSLABSAAREYDRUGSNECLIFEALBERTDAVDVALIANTLABNATCAPSUQZIMLABMcap ₹0.1 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations144.9150.9206.4237.5
Other Income2.12.75.96.4
Total Income147.0153.6212.3244.0
Expenses
+ Cost of Materials Consumed106.1111.4148.6167.1
+ Purchases of Stock-in-Trade1.82.14.45.0
+ Changes in Inventories2.0-5.2-1.77.7
+ Employee Benefit Expense5.96.37.47.7
+ Finance Costs0.81.21.81.9
+ Depreciation & Amortisation2.93.03.13.0
+ Other Expenses16.221.330.632.6
Total Expenses135.7140.1194.3225.0
EBITDA12.915.017.017.5
EBIT10.012.013.914.5
Profit
PBT before Exceptional Items11.313.518.119.0
Pretax Income11.313.518.119.0
+ Current Tax3.23.85.15.2
+ Deferred Tax-0.1-0.4-0.1-0.1
Tax Expense3.03.44.95.2
Net Income8.310.113.113.8
+ Net Income — Continuing Ops8.310.113.113.8
+ Other Comprehensive Income0.20.0-0.1-0.1
Total Comprehensive Income8.510.113.013.7
Per Share
Basic EPS1.001.221.582.02
Diluted EPS1.001.221.582.02
Other Comprehensive Income — detail
+ Other Comprehensive Income0.0-0.1-0.1
+ Items NOT to be Reclassified to P&L-0.1
+ Tax on Items NOT to be Reclassified-0.0-0.0-0.0
+ Tax on Items NOT to be Reclassified — alt tag-0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations1.001.221.581.67
Diluted EPS — Continuing Operations1.001.221.581.67
Basic EPS — Discontinued Operations0.000.000.000.35
Diluted EPS — Discontinued Operations0.000.000.000.35
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit35.042.655.057.8
Gross Margin %24.1628.2326.6724.33
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)11.313.518.119.0
Net Income Adj (tax-effected)8.310.113.113.8
EPS Adj1.001.221.582.02
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.005,887.772.00
Filed Debt Equity0.000.000.000.00
Filed Dscr0.000.000.110.00
Filed Iscr0.000.200.190.11
Paid Up Equity Capital16.616.616.616.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.